{
    "Clinical Trial ID": "NCT01237327",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Exemestane",
        "  Exemestane 25 milligram (mg) oral tablet taken once daily",
        "INTERVENTION 2: ",
        "  Megestrol Acetate",
        "  Megestrol acetate 160 mg tablet taken once daily"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Previous participation in study 971-ONC-0028-080.",
        "Exclusion Criteria:",
        "  Subjects who had not previously participated in study 971-ONC-0028-080."
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Overall Survival",
        "  Overall survival in months measured from date of starting treatment in core study to date of death for any reason.",
        "  Time frame: Every 12 weeks up to 6 years",
        "Results 1: ",
        "  Arm/Group Title: Exemestane",
        "  Arm/Group Description: Exemestane 25 milligram (mg) oral tablet taken once daily",
        "  Overall Number of Participants Analyzed: 43",
        "  Median (95% Confidence Interval)",
        "  Unit of Measure: months  29.2        (22.9 to 47.8)",
        "Results 2: ",
        "  Arm/Group Title: Megestrol Acetate",
        "  Arm/Group Description: Megestrol acetate 160 mg tablet taken once daily",
        "  Overall Number of Participants Analyzed: 41",
        "  Median (95% Confidence Interval)",
        "  Unit of Measure: months  16.3        (11.6 to 27.6)"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 1/41 (2.44%)",
        "  Chest pain NEC 0/41 (0.00%)",
        "  Back pain 0/41 (0.00%)",
        "  Cerebral haemorrhage 0/41 (0.00%)",
        "  Headache NOS 0/41 (0.00%)",
        "  Spinal cord compression 0/41 (0.00%)",
        "  Completed suicide 1/41 (2.44%)",
        "Adverse Events 2:",
        "  Total: 2/40 (5.00%)",
        "  Chest pain NEC 1/40 (2.50%)",
        "  Back pain 1/40 (2.50%)",
        "  Cerebral haemorrhage 1/40 (2.50%)",
        "  Headache NOS 1/40 (2.50%)",
        "  Spinal cord compression 1/40 (2.50%)",
        "  Completed suicide 0/40 (0.00%)"
    ]
}